AQR Capital Management
SZYM

AQR Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

AQR Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-225,000
Closed -$2.61M – 2649
2014
Q1 		$2.61M Buy
+225,000
New +$2.65M 0.01% 1155

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AQR Capital Management's SZYM Position: Q2 2014 in Review

AQR Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2014, closing a stake of 225,000 shares — an estimated $2.61M sold.

AQR Capital Management first reported a position in SZYM in Q1 2014 and held it in 1 quarter. The position peaked at $2.61M in Q1 2014. 124 funds tracked by Wall St. Rank hold SZYM as of Q2 2014.

  • AQR Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • AQR Capital Management sold 225,000 SOLAZYME INC COM STK (DE) shares in Q2 2014, an estimated $2.61M.
  • AQR Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • AQR Capital Management's SOLAZYME INC COM STK (DE) position peaked at $2.61M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2014.

Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.